DR

Dm Clinical Research

www.dmclinical.com link_icon

DM Clinical Research Company Market Research Report



Company Overview



Name


DM Clinical Research

Mission


To deliver advanced, preventative medicine to underserved communities and help bring novel medicines to the world.

Founding Information


  • Founded: 2006

  • Founder: Mohammad Millwala


Key People


  • CEO: Mohammad Millwala, MBA, CPA

  • Chief Strategy Officer: Zohair Harianawala, MBA, PMP

  • Chief Financial Officer: Mark Ubert

  • Executive Vice President of Strategy and Growth: Lisa Bjornestad

  • Vice President of Operational Strategy and Excellence: Shivani Shah, MS

  • Vice President of Strategic Relationships: Wes Bonner

  • Vice President of Business Development: Stephanie Ailey

  • Vice President of IT: Kent Black

  • Executive Director of Marketing & Patient Engagement: Hera Arham, MBA, MA

  • Executive Director of Business Services: Murtaza Marvi

  • Director of Site Operations: Chandra Tobin

  • Regional Director: Jennifer Hilton


Headquarters


7908 North Sam Houston Pkwy W #200, Houston, TX 77064

Number of Employees


No information is available

Revenue


No information is available

Company Recognition


DM Clinical is known for being the largest private clinical trial network in Texas and rapidly expanding across the United States. They specialize in high-quality, compassionate clinical trials with a strong focus on diverse patient enrollment.

Products and Services



Clinical Trials


DM Clinical conducts clinical trials across multiple therapeutic areas, specifically focusing on:
  • Vaccines

  • Internal Medicine

  • Pediatrics

  • Gastroenterology (GI)

  • Psychiatry

  • Women’s Health

  • Diabetes

  • COVID-19 Vaccine Trials

  • Migraine Studies


Key Features


1. Large Network of Research Sites: With 24+ dedicated research centers and expansions into Illinois, Pennsylvania, Michigan, Massachusetts, New York, New Jersey, and Arizona.
2. Experienced Principal Investigators: Each clinical trial is overseen by one of the company's own physicians.
3. Compensation for Participants: Participants are compensated for study-related time and travel.
4. Diversity in Enrollment: Commitment to enrolling a diverse patient population.

Recent Developments



New Products Launched


  • COVID-19 Vaccine Trial: Enrolling participants for new COVID-19 booster options.


New Features Added


  • Ambassador Program: A new initiative allowing participants to refer friends and family to clinical trials and receive compensation.


New Partnerships and Awards


  • SCRS Global Impact Partner: Recognized by SCRS as a Global Impact Partner.

  • Best Clinical Trial Network Award 2023: Received the Vaccine Industry Excellence Award.

  • Excellence in Patient Centricity Award: Honored for patient-centric approaches by SCRS.


Locations


DM Clinical has research sites in various locations:
  • Texas: Houston, Tomball, Irving, San Antonio

  • Illinois: Chicago

  • Arizona: Phoenix

  • Massachusetts: Boston

  • Michigan: Detroit

  • New Jersey: Jersey City

  • New York: Brooklyn

  • Pennsylvania: Philadelphia

  • Washington: Seattle

  • New Mexico: Albuquerque


Contact Information


  • Phone: 281-517-0550

  • Email: ask@dmclinical.com

  • Address: 7908 North Sam Houston Pkwy W #200, Houston, TX 77064






This report presents the essential details of DM Clinical Research, focusing on the company's background, key people, services offered, recent developments, and contact information. The information provided is comprehensive and derived from available data without additional commentary.